Conventional morphologic criteria as studied in routine Haematoxylin and Eosin stained sections (H & E) may not be accurate in grading and assessing prognosis in small stereotactic biopsy specimens. Thus, arises the need for objective methods for assessing tumour biology. Angiogenesis is a key event in the spread of tumours and denotes a poor prognosis. Intratumoural Microvessel Density (MVD) helps in quantification of angiogenesis.

MIB-1 index LI is an important complementary tool to accurately grade meningothelial tumours and assess tumour biology. Specific cycling endothelial markers along with CD 34 & MVD could be used to assess the prognosis of these tumours 1).

Due to variation between institutions and observers, it is advised that proliferation indices (e.g. Ki-67 or MIB-1 not be used as the sole discriminant for grading. However, these indices do correlate with prognosis. Adding the phrase “with high proliferative activity” is suggested for tumors with a very high index 2).


1)
Bohra H, Rathi KR, Dudani S, Bohra A, Vishwakarma S, Sahai K. The Study of MIB-1 LI and CD 34 As A Marker of Proliferative Activity and Angiogenesis in Different Grades of Meningioma. J Clin Diagn Res. 2016 Aug;10(8):EC14-7. doi: 10.7860/JCDR/2016/12690.8328. Epub 2016 Aug 1. PubMed PMID: 27656445; PubMed Central PMCID: PMC5028582.
2)
Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous sys- tem. J Neuropathol Exp Neurol. 2002; 61:215–25; discussion 226-9
  • meningioma_proliferation_index.txt
  • Last modified: 2024/06/07 03:00
  • by 127.0.0.1